Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05450900 · ClinicalTrials.gov registry record · Early Phase 1
Can Biotin Supplementation be Used to Mask hCG Abuse?
A Early Phase 1 study, sponsored by Sports Medicine Research and Testing Laboratory.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT05450900 is a Early Phase 1 study that has completed, run by Sports Medicine Research and Testing Laboratory. The registered enrollment target is 10 participants.
The verdict
NCT05450900, a Early Phase 1 study, has completed, sponsored by Sports Medicine Research and Testing Laboratory.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This sponsor is an anti-doping laboratory tasked with testing athlete samples for prohibited substances by the World Anti-Doping Agency and other agencies. This study is intended to measure: 1. Urinary/serum hCG (human chorionic gonadotropin) and urinary biotin concentrations in both treatment groups before, during, and after hCG intervention using standard immunoassay methods 2. To monitor hCG in both treatment groups before and after diafiltration of urine samples prior to analysis 3. To compare urinary and serum detectability (detection window, sensitivity) of hCG abuse in the hCG-only group compared to the hCG + biotin group
Interventions
- DIETARY_SUPPLEMENT biotin
- DRUG Choriogonadotropin Alpha
- OTHER Microcellulose filler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-10-27 |
| Est. Completion | 2023-02-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05450900
The ClinicalTrials.gov registry entry for NCT05450900 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sports Medicine Research and Testing Laboratory, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which biotin is the first listed.
NCT05450900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05450900 about?
NCT05450900 is a clinical study titled "Can Biotin Supplementation be Used to Mask hCG Abuse?". This sponsor is an anti-doping laboratory tasked with testing athlete samples for prohibited substances by the World Anti-Doping Agency and other agencies. This study is intended to measure: 1. Urinary/serum hCG (human chorionic gonadotropin) and urinary biotin concentrations in both treatment gro...
What is the current status of trial NCT05450900?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2022-10-27. Estimated completion is 2023-02-02.
What interventions are being tested in trial NCT05450900?
The interventions under investigation include: biotin (DIETARY_SUPPLEMENT), Choriogonadotropin Alpha (DRUG), Microcellulose filler (OTHER).
Who is sponsoring clinical trial NCT05450900?
This trial is sponsored by Sports Medicine Research and Testing Laboratory, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.